Click Therapeutics raises $52M, looks to advance digital therapeutics


Click Therapeutics is developing digital therapeutics for depression, insomnia and other conditions. It plans to use the funds to commercialize its therapeutics, through partnerships with pharmaceutical companies including Otsuka.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.